⏳ Fetching live dividend data...
Home › Calculator › PKI Dividend Calculator 2026
PerkinElmer, Inc. · NYSE
Price: $115.24 · Annual div: $0.28/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
PKI is not a dividend-focused stock
PKI pays a very low or no dividend (Yield: 0.24%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in PKI → $386.98 in 10 years · $0.00/month
PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PKI position with:
Real after-tax yield depends on where you live and how you hold PKI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.24% | -2.56% | $24 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.20% | -2.60% | $20 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.19% | -2.61% | $19 / yr |
| 🇬🇧 UK ISA | 0% | 0.24% | -2.56% | $24 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.22% | -2.58% | $22 / yr |
| 🇨🇦 TFSA | 0% | 0.24% | -2.56% | $24 / yr |
| 🇨🇦 CA Taxable | 25% | 0.18% | -2.62% | $18 / yr |
| 🇦🇺 Super (pension) | 15% | 0.20% | -2.60% | $20 / yr |
| 🇦🇺 AU Taxable | 30% | 0.17% | -2.63% | $17 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.18% | -2.62% | $18 / yr |
| 🇫🇷 FR Taxable | 30% | 0.17% | -2.63% | $17 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.28/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
PKI pays quarterly — 4 times per year. Next ex-div: TBD.
How PKI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PKI sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2023-12-15 | 248 | — | — | ||
| A-Award | 2023-12-15 | 706 | $101.36 | $71.6K | ||
| G-Gift | 2023-11-27 | 250 | — | — | ||
| G-Gift | 2023-11-28 | 230 | — | — | ||
| A-Award | 2023-06-15 | 329 | — | — | ||
| A-Award | 2023-06-15 | 947 | $116.36 | $110.2K | ||
| A-Award | 2023-05-15 | 955 | — | — | ||
| A-Award | 2023-05-15 | 783 | — | — | ||
| A-Award | 2023-05-15 | 1,372 | — | — | ||
| A-Award | 2023-05-15 | 1,061 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PKI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
PerkinElmer, Inc. (PKI) is currently trading at $115.24, trading near its 52-week low. The current dividend yield is 0.24% based on an annual payout of $0.28 per share.
PerkinElmer, Inc. (PKI) is a healthcare stock currently trading at $115.24 with a dividend yield of 0.24%. The company pays an annual dividend of $0.28 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, PKI has grown its dividend at a compound annual rate of 50.0%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever